2d and Extended Data Fig
Available from: Gouvrion L, Delage M, Villani AP, Le Naour S, Fite C, Cassius C, et al
Researchers examine dose-response relationships and time-course effects to characterize how the peptide interacts with the stress hormone cascade under controlled laboratory conditions
These can include nausea, constipation, diarrhoea, fatigue, headaches, and muscle loss, hair loss and weakened skin elasticity due to the impact of rapid weight loss on the body
99 Dihydromyricetin stimulates GLP-1 secretion through the cAMP signaling pathway and inhibits dipeptidyl peptidase (DPP)-4 expression in the colon, increasing circulating GLP-1 levels